Tusk Therapeutics to be acquired by Roche

Tusk Therapeutics Ltd has been acquired by Roche. Tusk was founded in 2014 by Droia Oncology Ventures, Tusk’s majority shareholder. Under the terms of...

PharmaDoctor and Star enter into a strategic partnership

PharmaDoctor (owned by Escripts Marketing Ltd), and Star (part of the Uniphar Group), are pleased to announce a strategic partnership between the two companies...

Novo Nordisk acquires Ziylo to accelerate glucose responsive insulin

Ziylo and Novo Nordisk have announced that Novo Nordisk has acquired all of the shares of Ziylo, a University of Bristol spin-out company based...

Syneos Health acquires advisory & operational solutions provider Kinapse

Syneos Health, Inc. a biopharmaceutical solutions organisation, has announced the acquisition of Kinapse, a market leading advisory and operational solutions provider to the global...

Almirall acquires US medical dermatology portfolio from Allergan

Almirall, S.A. (ALM) has announced the acquisition of a portfolio of five products from Allergan’s Medical Dermatology unit in the United States for $500...

UDG Healthcare acquire Create NYC and SmartAnalyst

UDG Healthcare plc, an international healthcare services provider, is pleased to announce the acquisition of Create NYC, a New York-based disruptive creative communications agency...

Laekna acquires worldwide rights to two oncology assets

Laekna Inc., a biotechnology company headquartered in Shanghai, announced the signing of an agreement with Novartis Pharma for exclusive global rights to develop and...

LEO Pharma to acquire Bayer’s dermatology unit

LEO Pharma has entered into a definitive agreement to buy Bayer's global prescription dermatology unit. The portfolio to be acquired includes branded topical prescription...

AstraZeneca sells rights for Atacand to Cheplapharm

AstraZeneca has agreed to sell the commercial rights to Atacand (candesartan cilexetil) and Atacand Plus (fixed-dose combination of candesartan cilexetil and hydrochlorothiazide) in Europe...

NanoGenics acquired to advance gene therapy

The Scottish Biotech company Ryboquin, announces the acquisition of Nanogenic Solutions, to form a new product and platform company, Nanogenics Limited. The combined company,...

Latest articles

Image of four people communicating via different mediums to depict mind the Generation Gap in pharma marketing

Mind the Generation Gap in pharma marketing and market research

Industry came together to explore the impact of the generation gap in pharma marketing and market research at BHBIA's summer event. Different generations have always...
AstraZeneca presents results from Phase III TULIP 2 trial for anifrolumab

AstraZeneca presents anifrolumab results from Phase III TULIP trial

Results from the positive Phase III TULIP 2 trial for AstraZeneca's anifrolumab, a potential new medicine for the treatment of moderate to severe systemic...
Scottish flag showing Novartis advanced breast cancer treatment approved in Scotland

Novartis advanced breast cancer treatment approved in Scotland

Novartis’ Kisqali® (ribociclib) in combination with fulvestrant receives recommendation from Scottish Medicines Consortium as advanced breast cancer treatment for patients with the most common...

Popular articles

People sitting around a desk with laptops and tablets to show NHS Commercial Framework for Medicines published for consultation

NHS Commercial Framework for Medicines consultation published

NHS England has published the NHS Commercial Framework for Medicines for consultation. NHS England has a significant role to play in supporting patient access to...
Mapping NHS change is key to customer engagement

Mapping NHS change is key to customer engagement

Simon Grime, of Wilmington Healthcare, explains how mapping NHS change through data and intelligence can help industry understand and engage customers in the new...
Pharmafield logo in lightbulb: Pf Power List 2019

Pf Power List 2019: Who is shaping the pharma & healthcare sector?

The Pf Power List has looked at who is making a difference in pharma and healthcare in 2019. This year has brought a range of developments...
Scottish flag showing Novartis advanced breast cancer treatment approved in Scotland

Novartis advanced breast cancer treatment approved in Scotland

Novartis’ Kisqali® (ribociclib) in combination with fulvestrant receives recommendation from Scottish Medicines Consortium as advanced breast cancer treatment for patients with the most common...
Image of a head with squiggly lines in the brain and cogs on top to indicate Medopad and Janssen collaborate on novel digital biomarker for Alzheimer's disease

Medopad and Janssen collaborate on novel digital biomarker for Alzheimer’s disease

Medopad has announced a strategic collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to validate, scale and...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription